Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock
Journal of Thrombosis and Haemostasis · 2025-06 · 23 (6) · 1810-1816
DOI: 10.1016/j.jtha.2025.02.028 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-06. Verfasst von Charlotte J Van Edom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, University Hospitals of Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University of Leuven, …. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Heart-Assist Devices, Blood Coagulation, Factor Xa Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
BACKGROUND: Managing unfractionated heparin (UFH) during percutaneous mechanical circulatory support for cardiogenic shock (CS) is challenging due to potential discrepancies between coagulation tests. OBJECTIVES: To study the causes and consequences of discrepancies between anti-Xa and activated partial thromboplastin time (APTT) for UFH monitoring during microaxial flow pump support (Impella) for CS. METHODS: We assessed patients in CS supported with Impella in 2 tertiary care centers over 62 months. UFH was titrated based on anti-Xa levels with parallel APTT measurements. In-range anti-Xa levels were considered between 0.20 and 0.30 IU/mL or 0.31 and 0.50IU/mL, and the corresponding APTT values were 40 to 55 seconds and 56 to 80 seconds, respectively. Pearson correlation was calculated between anti-Xa and APTT. Samples with in-range anti-Xa but prolonged APTT were analyzed for abnormalities in international normalized ratio (INR; ≥1.5) and/or fibrinogen (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Diseases, University Hospitals of Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
- Department of Cardiology and Cardiac Intensive Care, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Departments of Cardiology and Intensive Care, University Hospital Brussels, Jette, Belgium.
- Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Cardiology and Cardiac Intensive Care, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK; Heart Center, OLV Aalst, Aalst, Belgium; Division of Anaesthetics, Pain…
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Van Edom, C. J., Fiorelli, F., Balthazar, T., Monteagudo-Vela, M., Vanassche, T., Panoulas, V. F., & Vandenbriele, C. (2025). Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock. Journal of Thrombosis and Haemostasis, 23(6), 1810-1816. https://doi.org/10.1016/j.jtha.2025.02.028
Vancouver
Van Edom CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, Vanassche T, Panoulas VF, et al. Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock. Journal of Thrombosis and Haemostasis. 2025;23(6):1810-1816. doi:10.1016/j.jtha.2025.02.028
BibTeX
@article{VanEdom2025,
author = {Van Edom, Charlotte J and Fiorelli, Francesca and Balthazar, Tim and Monteagudo-Vela, Maria and Vanassche, Thomas and Panoulas, Vasileios F and Vandenbriele, Christophe},
title = {Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {6},
pages = {1810--1816},
doi = {10.1016/j.jtha.2025.02.028}
}
EUVIMED